Sonic Healthcare (SHL) AGM 2025 summary

Opening remarks and agenda

• Meeting opened with acknowledgment of traditional custodians, confirmation of quorum, and presentations from CEO and incoming CEO.

• Hybrid format enabled both in-person and online participation, with real-time Q&A and voting.

• Board members, incoming CEO, and auditors introduced; voting procedures and poll process explained.

Board and executive committee updates

• Dr. Colin Goldschmidt retired as CEO after 32 years, succeeded by Dr. Jim Newcombe, who brings medical and commercial leadership experience.

• Dr. Goldschmidt will remain as advisor and chair of the Sonic Healthcare Foundation.

• Evangelos Kotsopoulos appointed as Chief Operating Officer, strengthening the executive team.

• Board renewal continued with the appointment of Nicola Wakefield Evans and planned future recruitment.

Financial performance review

• FY 2025 revenue reached A$9,645M, up 8% from prior year; net profit A$514M, EBITDA A$1,725M, and cash from operations up 21%.

• Organic revenue growth was 5%, with normalised EBITDA margin expanding by 40bps.

• FY 2026 revenue expected to exceed A$10B, possibly reaching A$11B; EBITDA guidance reaffirmed at A$1.87–1.95B.

• Statutory revenue growth YTD Oct 2025 was 17%, with 12% constant currency growth.

• LADR acquisition in Germany and NHS contract in the UK contributed to growth.